Abstract
The objective of this study was to introduce and evaluate UV imaging technology for real-time characterization of drug diffusion in and release from hydrogels. Piroxicam and human serum albumin diffusion in Pluronic F127 hydrogel was monitored by measuring the absorbance of light passing through the diffusion cell at 26 °C, thus providing real-time concentration maps (7 × 3 mm imaging area) within the gel as a function of time. Apparent diffusion coefficients were obtained on the basis of Fick’s second law. Piroxicam and human serum albumin diffusivities in 20% (w/w) F127 gel were 8 and 24 times lower than those determined in the phosphate buffer (pH 7.4). The effect of increasing polymer concentration (20%, 25% and 30% (w/w)) on piroxicam diffusion was further investigated. The decreasing diffusion rate with increasing F127 concentration agreed well with small-angle X-ray scattering (SAXS) measurements. UV imaging was also successfully applied to monitor piroxicam release from 30% (w/w) F127 gel into a stirred aqueous buffer solution, providing simultaneous information on gel dissolution rate, change in thickness of gel–aqueous boundary layer as well as the release of piroxicam into bulk aqueous phase. The current study indicates that UV imaging has great potential for measuring drug diffusion in and release from gel matrices. Compared to the currently used conventional techniques, this technology has several advantages including high information content, non-intrusive measurements without the need for labeling, flexibility with respect to experimental design and simplicity of operation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.